LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Health & Fitness
• Education
• Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cancer, google, scholar, pubmed, breast, proliferative, activity, response, prognostic, cell, chemotherapy, proliferation, human, tumor, tumors, survival, res, article, patients, primary, growth, pathol, content, analysis, bonetti, low, rate, index, data, advanced, carcinoma, estrogen, oncol, monoclonal, receptors, silvestrini, privacy, cookies, research, relationship, significance, cancers, fraction, treat, clinical, gerdes, stein, antibody, antigen, nonhodgkin,

Topics {✒️}

node-negative breast cancers month download article/chapter node-negative breast cancer 3h-thimidine-labeling index peripheral t-cell lymphoma diffuse large-cell lymphomas node-positive breast cancer advanced breast cancer advanced breast carcinoma privacy choices/manage cookies nc campos-filho node-negative stage o'brien cj long-term prognostic factor human breast cancers nucleolar organizer region tritiated thymidine labeling tumor proliferative activity full article pdf pretreatment proliferative activity breast cancer evaluated disseminated breast cancer /ii breast carcinoma operable breast carcinoma thymidine labeling index primary breast cancer short-term recurrences human nuclear antigen human breast cancer programmed cell death ki-67 labeling index human breast carcinomas cell proliferation kinetics european economic area ki-67 immunohistologic staining multivariate analy-sis c-myc p62 peanut lectin binding prognostic subgroups defined tumor proliferative rate cell cycle analysis cell kinetics induced monoclonal antibody ki-67 chemotherapy source book el-naggar ak conditions privacy policy low proliferative activity s-phase fraction high-proliferative activity soft tissue metastases

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma
         description:The relationship between tumor proliferative activity and response to first-line chemotherapy and survival was investigated in 76 advanced breast cancer patients. Proliferative activity was determined by means of Ki-67 immunohistologic staining on primary tumors (55 patients) or at the relapse site (21 patients), and was classified as low (≤ 25% of stained cells) or high (> 25% of stained cells). The usual WHO response criteria were used. The median duration of follow-up was 18 months (range 3–58). Forty-seven patients (62%) had tumors with low, and 29 (38%) had tumors with a high rate of proliferative activity. The two groups were well balanced in terms of important variables such as disease-free survival, performance status, age, menopausal status, and the type of first-line chemotherapy (anthracycline-based regimens versus cyclophosphamide-methotrexate-5-fluorouracil). The estrogen receptor (ER) content, measured by means of immunohistochemical assay, was markedly different in the two groups, with 27/47 tumors with low proliferative activity (57%) and 6/29 with high-proliferative activity (21%) being ER positive (≥ 45% of stained cells) (p = 0.003). Moreover, a significant difference in the metastatic pattern was also evident, with a higher incidence of bone and a lower incidence of soft tissue metastases in the group of patients with tumors with low proliferative activity (p = 0.004). Overall, 10/47 responses (21%: PR = 7, and CR = 3) were observed in the group with a low rate of proliferative activity, versus 14/29 (48%: PR = 9, and CR = 5) in the group with highly proliferative tumors, the difference being statistically significant (p = 0.03). When a multivariate analy-sis was performed, the only factor that retained independent prognostic significance was the predominant site of disease, particularly soft tissues (p = 0.003). Despite the difference in response rate, when survival analysis was performed according to the Kaplan-Meier method, no significant difference was observed in the two groups, but when the analysis was limited to responsive patients, the median survival observed in those with a low and those with a high rate of proliferation was 35 and 19 months respectively (p = 0.02). The same results were obtained when multivariate survival analysis was carried out using Cox's regression model. These data suggest that there is a link between tumor proliferative activity and response to chemotherapy in advanced breast cancer, and may indicate the need to use more intensive treatments in selected patients with highly proliferative tumors.
         datePublished:
         dateModified:
         pageStart:289
         pageEnd:297
         sameAs:https://doi.org/10.1007/BF01806148
         keywords:
            advanced breast cancer
            chemotherapy
            proliferative activity
            Ki-67 immunostaining
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:38
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Andrea Bonetti
               affiliation:
                     name:Civic Hospital of Borgo Trento and University of Verona
                     address:
                        name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marta Zaninelli
               affiliation:
                     name:Civic Hospital of Borgo Trento and University of Verona
                     address:
                        name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stefania Rodella
               affiliation:
                     name:Civic Hospital of Borgo Trento and University of Verona
                     address:
                        name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Annamaria Molino
               affiliation:
                     name:Civic Hospital of Borgo Trento and University of Verona
                     address:
                        name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Loris Sperotto
               affiliation:
                     name:Civic Hospital of Borgo Trento and University of Verona
                     address:
                        name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Quirino Piubello
               affiliation:
                     name:Civic Hospital of Borgo Trento and University of Verona
                     address:
                        name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Franco Bonetti
               affiliation:
                     name:Civic Hospital of Borgo Trento and University of Verona
                     address:
                        name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rolando Nortilli
               affiliation:
                     name:Civic Hospital of Borgo Trento and University of Verona
                     address:
                        name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Monica Turazza
               affiliation:
                     name:Civic Hospital of Borgo Trento and University of Verona
                     address:
                        name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gian Luigi Cetto
               affiliation:
                     name:Civic Hospital of Borgo Trento and University of Verona
                     address:
                        name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma
      description:The relationship between tumor proliferative activity and response to first-line chemotherapy and survival was investigated in 76 advanced breast cancer patients. Proliferative activity was determined by means of Ki-67 immunohistologic staining on primary tumors (55 patients) or at the relapse site (21 patients), and was classified as low (≤ 25% of stained cells) or high (> 25% of stained cells). The usual WHO response criteria were used. The median duration of follow-up was 18 months (range 3–58). Forty-seven patients (62%) had tumors with low, and 29 (38%) had tumors with a high rate of proliferative activity. The two groups were well balanced in terms of important variables such as disease-free survival, performance status, age, menopausal status, and the type of first-line chemotherapy (anthracycline-based regimens versus cyclophosphamide-methotrexate-5-fluorouracil). The estrogen receptor (ER) content, measured by means of immunohistochemical assay, was markedly different in the two groups, with 27/47 tumors with low proliferative activity (57%) and 6/29 with high-proliferative activity (21%) being ER positive (≥ 45% of stained cells) (p = 0.003). Moreover, a significant difference in the metastatic pattern was also evident, with a higher incidence of bone and a lower incidence of soft tissue metastases in the group of patients with tumors with low proliferative activity (p = 0.004). Overall, 10/47 responses (21%: PR = 7, and CR = 3) were observed in the group with a low rate of proliferative activity, versus 14/29 (48%: PR = 9, and CR = 5) in the group with highly proliferative tumors, the difference being statistically significant (p = 0.03). When a multivariate analy-sis was performed, the only factor that retained independent prognostic significance was the predominant site of disease, particularly soft tissues (p = 0.003). Despite the difference in response rate, when survival analysis was performed according to the Kaplan-Meier method, no significant difference was observed in the two groups, but when the analysis was limited to responsive patients, the median survival observed in those with a low and those with a high rate of proliferation was 35 and 19 months respectively (p = 0.02). The same results were obtained when multivariate survival analysis was carried out using Cox's regression model. These data suggest that there is a link between tumor proliferative activity and response to chemotherapy in advanced breast cancer, and may indicate the need to use more intensive treatments in selected patients with highly proliferative tumors.
      datePublished:
      dateModified:
      pageStart:289
      pageEnd:297
      sameAs:https://doi.org/10.1007/BF01806148
      keywords:
         advanced breast cancer
         chemotherapy
         proliferative activity
         Ki-67 immunostaining
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:38
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Andrea Bonetti
            affiliation:
                  name:Civic Hospital of Borgo Trento and University of Verona
                  address:
                     name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marta Zaninelli
            affiliation:
                  name:Civic Hospital of Borgo Trento and University of Verona
                  address:
                     name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stefania Rodella
            affiliation:
                  name:Civic Hospital of Borgo Trento and University of Verona
                  address:
                     name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Annamaria Molino
            affiliation:
                  name:Civic Hospital of Borgo Trento and University of Verona
                  address:
                     name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Loris Sperotto
            affiliation:
                  name:Civic Hospital of Borgo Trento and University of Verona
                  address:
                     name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Quirino Piubello
            affiliation:
                  name:Civic Hospital of Borgo Trento and University of Verona
                  address:
                     name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Franco Bonetti
            affiliation:
                  name:Civic Hospital of Borgo Trento and University of Verona
                  address:
                     name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rolando Nortilli
            affiliation:
                  name:Civic Hospital of Borgo Trento and University of Verona
                  address:
                     name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Monica Turazza
            affiliation:
                  name:Civic Hospital of Borgo Trento and University of Verona
                  address:
                     name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gian Luigi Cetto
            affiliation:
                  name:Civic Hospital of Borgo Trento and University of Verona
                  address:
                     name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:38
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Civic Hospital of Borgo Trento and University of Verona
      address:
         name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
         type:PostalAddress
      name:Civic Hospital of Borgo Trento and University of Verona
      address:
         name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
         type:PostalAddress
      name:Civic Hospital of Borgo Trento and University of Verona
      address:
         name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
         type:PostalAddress
      name:Civic Hospital of Borgo Trento and University of Verona
      address:
         name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
         type:PostalAddress
      name:Civic Hospital of Borgo Trento and University of Verona
      address:
         name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
         type:PostalAddress
      name:Civic Hospital of Borgo Trento and University of Verona
      address:
         name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
         type:PostalAddress
      name:Civic Hospital of Borgo Trento and University of Verona
      address:
         name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
         type:PostalAddress
      name:Civic Hospital of Borgo Trento and University of Verona
      address:
         name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
         type:PostalAddress
      name:Civic Hospital of Borgo Trento and University of Verona
      address:
         name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
         type:PostalAddress
      name:Civic Hospital of Borgo Trento and University of Verona
      address:
         name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Andrea Bonetti
      affiliation:
            name:Civic Hospital of Borgo Trento and University of Verona
            address:
               name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
               type:PostalAddress
            type:Organization
      name:Marta Zaninelli
      affiliation:
            name:Civic Hospital of Borgo Trento and University of Verona
            address:
               name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
               type:PostalAddress
            type:Organization
      name:Stefania Rodella
      affiliation:
            name:Civic Hospital of Borgo Trento and University of Verona
            address:
               name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
               type:PostalAddress
            type:Organization
      name:Annamaria Molino
      affiliation:
            name:Civic Hospital of Borgo Trento and University of Verona
            address:
               name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
               type:PostalAddress
            type:Organization
      name:Loris Sperotto
      affiliation:
            name:Civic Hospital of Borgo Trento and University of Verona
            address:
               name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
               type:PostalAddress
            type:Organization
      name:Quirino Piubello
      affiliation:
            name:Civic Hospital of Borgo Trento and University of Verona
            address:
               name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
               type:PostalAddress
            type:Organization
      name:Franco Bonetti
      affiliation:
            name:Civic Hospital of Borgo Trento and University of Verona
            address:
               name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
               type:PostalAddress
            type:Organization
      name:Rolando Nortilli
      affiliation:
            name:Civic Hospital of Borgo Trento and University of Verona
            address:
               name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
               type:PostalAddress
            type:Organization
      name:Monica Turazza
      affiliation:
            name:Civic Hospital of Borgo Trento and University of Verona
            address:
               name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
               type:PostalAddress
            type:Organization
      name:Gian Luigi Cetto
      affiliation:
            name:Civic Hospital of Borgo Trento and University of Verona
            address:
               name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
      name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
      name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
      name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
      name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
      name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
      name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
      name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
      name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
      name:From the Department of Medical Oncology and Pathology, Civic Hospital of Borgo Trento and University of Verona, Verona, Italy
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(146)

• https://www.springernature.com/gp/authors's total income per month
• Profit of https://link.springernature.com/home/
• Get to know https://order.springer.com/public/cart's earnings
• https://submission.springernature.com/new-submission/10549/3 income
• What's the financial outcome of https://www.springernature.com/gp/librarians/licensing/agc/journals?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Tumor%20cell%20proliferation%20kinetics%20and%20tumor%20growth%20rate&journal=Acta%20Oncol&volume=28&pages=113-121&publication_year=1988&author=Tubiana%2CM?
• How much does http://scholar.google.com/scholar_lookup?&title=The%20growth%20fraction%3A%20a%20new%20concept%20applied%20to%20tumors&journal=Science&volume=132&publication_year=1960&author=Mendelsohn%2CML net monthly?
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1026343
• Get to know http://scholar.google.com/scholar_lookup?&title=Comparison%20of%20cell%20proliferation%20kinetics%20in%20human%20and%20experimental%20tumors%3A%20response%20to%20irradiation&journal=Cancer%20Treat%20Rep&volume=60&pages=1887-1895&publication_year=1976&author=Tubiana%2CM&author=Malaise%2CEP's earnings
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2181096 rake in every month?
• How much does http://scholar.google.com/scholar_lookup?&title=The%20clinical%20assessment%20of%20proliferation%20and%20growth%20in%20human%20tumours%3A%20evaluation%20of%20methods%20and%20applications%20as%20prognostic%20variables&journal=J%20Pathol&volume=160&pages=93-102&publication_year=1990&author=Quinn%2CCM&author=Wright%2CNA earn?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6339421 net monthly?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Production%20of%20a%20mouse%20monoclonal%20antibody%20reactive%20with%20a%20human%20nuclear%20antigen%20associated%20with%20cell%20proliferation&journal=Int%20J%20Cancer&volume=31&pages=13-20&publication_year=1983&author=Gerdes%2CJ&author=Schwab%2CU&author=Lemke%2CH&author=Stein%2CH
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6206131?
• How much does http://scholar.google.com/scholar_lookup?&title=Cell%20cycle%20analysis%20of%20a%20cell%20proliferation-associated%20human%20nuclear%20antigen%20defined%20by%20the%20monoclonal%20antibody%20Ki-67&journal=J%20Immunol&volume=133&pages=1710-1715&publication_year=1984&author=Gerdes%2CJ&author=Lemke%2CH&author=Baisch%2CH&author=Wacker%2CHH&author=Schwab%2CU&author=Stein%2CH gross monthly?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Growth%20fractions%20in%20malignant%20non-Hodgkin%20lymphomas%20%28NHL%29%20as%20determinedin%20situ%20with%20the%20monoclonal%20antibody%20Ki-67&journal=Hemathol%20Oncol&volume=2&pages=365-371&publication_year=1984&author=Gerdes%2CJ&author=Dallenbach%2CF&author=Lennert%2CK&author=Lemke%2CH&author=Stein%2CH?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2536520
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Thymidine%20labeling%20index%20and%20Ki-67%20growth%20fraction%20in%20lesions%20of%20the%20breast&journal=Am%20J%20Pathol&volume=134&pages=107-113&publication_year=1989&author=Kamel%2COW&author=Franklin%2CWA&author=Ringus%2CJC&author=Meyer%2CJS is on a monthly basis
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2472168
• Find out how much http://scholar.google.com/scholar_lookup?&title=Ki-67%20immunostaining%20in%20primary%20breast%20cancer%3A%20pathological%20and%20clinical%20associations&journal=Br%20J%20Cancer&volume=59&pages=943-947&publication_year=1989&author=Bouzubar%2CN&author=Walker%2CKJ&author=Griffiths%2CK&author=Ellis%2CIO&author=Elston%2CCW&author=Robertson%2CJF&author=Blamey%2CRW&author=Nicholson%2CRI earns monthly
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2371973 generate?
• How much does http://scholar.google.com/scholar_lookup?&title=Ki-67%20labeling%20index%20is%20a%20more%20reliable%20measure%20of%20solid%20tumor%20proliferative%20activity%20than%20tritiated%20thymidine%20labeling&journal=Am%20J%20Clin%20Pathol&volume=94&pages=192-195&publication_year=1990&author=Deshmukh%2CP&author=Ramsey%2CL&author=Garewal%2CHS bring in each month?
• How much income does http://scholar.google.com/scholar_lookup?&title=Ki-67%20index%20and%20S-phase%20fraction%20in%20human%20breast%20carcinomas.%20Comparison%20and%20correlation%20with%20prognostic%20factors&journal=Am%20J%20Pathol&volume=94&pages=681-686&publication_year=1990&author=Vielh%2CP&author=Chevillard%2CS&author=Mosseri%2CV&author=Donatini%2CB&author=Magdelenat%2CH have?
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8217353?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Cell%20proliferation%20of%20breast%20cancer%20evaluated%20by%20anti-BrdU%20and%20anti-Ki-67%20antibodies%3A%20its%20prognostic%20value%20on%20short-term%20recurrences&journal=Eur%20J%20Cancer&volume=29A&pages=1509-1513&publication_year=1993&author=Gaglia%2CP&author=Bernardi%2CA&author=Venesio%2CT&author=Caldarola%2CB&author=Lauro%2CD&author=Cappa%2CAPM&author=Calderini%2CP&author=Liscia%2CDS
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2205375?
• How much money does http://scholar.google.com/scholar_lookup?&title=Comprehensive%20management%20of%20disseminated%20breast%20cancer&journal=Cancer&volume=66&pages=1439-1448&publication_year=1990&author=Henderson%2CIC&author=Garber%2CJE&author=Breitmeyer%2CJB&author=Hayes%2CDF&author=Harris%2CJR make?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7459811 earning monthly?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Reporting%20results%20of%20cancer%20treatment&journal=Cancer&volume=47&pages=207-214&publication_year=1981&author=Miller%2CAB&author=Hoogstraten%2CB&author=Staquet%2CM&author=Winkler%2CA
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3501245 make?
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Growth%20fractions%20and%20estrogen%20receptors%20in%20human%20breast%20cancers%20as%20determinedin%20situ%20with%20monoclonal%20antibodies&journal=Am%20J%20Pathol&volume=129&pages=486-492&publication_year=1987&author=Gerdes%2CJ&author=Pickartz%2CH&author=Brotherton%2CJ&author=Hammerstein%2CJ&author=Weitzel%2CH&author=Stein%2CH?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3978544
• Income figures for http://scholar.google.com/scholar_lookup?&title=Immunohistologic%20localization%20of%20estrogen%20receptors%20in%20breast%20cancer%20with%20monoclonal%20antibodies&journal=Cancer&volume=55&pages=1513-1518&publication_year=1985&author=Pertschuk%2CLP&author=Eisenberg%2CKB&author=Carter%2CAC&author=Feldman%2CJG
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7579486 bring in each month?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Estrogen%20receptors%20in%20699%20primary%20breast%20cancers%3A%20a%20comparison%20of%20immunohistochemical%20and%20biochemical%20methods&journal=Breast%20Cancer%20Res%20Treat&volume=34&pages=221-228&publication_year=1995&author=Molino%2CA&author=Micciolo%2CR&author=Turazza%2CM&author=Bonetti%2CF&author=Piubello%2CQ&author=Corgnati%2CA&author=Sperotto%2CL&author=Martignoni%2CG&author=Bonetti%2CA&author=Nortilli%2CR&author=Castelli%2CP&author=Rodella%2CS&author=Capelli%2CP&author=Manfrin%2CE&author=Pelosi%2CG&author=Cetto%2CGL is on a monthly basis
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Assessing%20significance%20in%20a%20fourfold%20table&pages=19-32&publication_year=1981&author=Fleiss%2CLJ
• Earnings of http://scholar.google.com/scholar_lookup?&title=Applied%20Logistic%20Regression&publication_year=1989&author=Hosmer%2CDW&author=Lemeshow%2CS
• How much profit does http://scholar.google.com/scholar_lookup?&title=Non-parametric%20estimation%20from%20incomplete%20observations&journal=J%20Am%20Stat%20Assoc&volume=53&pages=457-461&publication_year=1958&author=Kaplan%2CEL&author=Meier%2CP make?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=5910392's gross income?
• What's the income of http://scholar.google.com/scholar_lookup?&title=Evaluation%20of%20survival%20data%20and%20two%20new%20rank%20order%20statistics%20arising%20in%20its%20consideration&journal=Cancer%20Chemother%20Rep&volume=50&pages=163-170&publication_year=1966&author=Mantel%2CN?
• How much money does http://scholar.google.com/scholar_lookup?&title=COXSURV%3A%20a%20microcomputer%20program%20for%20multiple%20regression%20by%20Cox%20proportional%20hazards%20model&journal=Comp%20Meth%20Prog%20Biomed&volume=31&pages=81-87&publication_year=1990&author=Campos-Filho%2CN&author=Franco%2CEL make?
• How much income does http://scholar.google.com/scholar_lookup?&title=KMSURV%3A%20a%20microcomputer%20program%20for%20univariate%20survival%20data%20analysis&journal=Comp%20Meth%20Prog%20Biomed&volume=27&pages=223-228&publication_year=1988&author=Campos-Filho%2CN&author=Franco%2CEL have?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8508358 generate?
• How much income is http://scholar.google.com/scholar_lookup?&title=Proliferation%20index%20as%20a%20prognostic%20marker%20in%20breast%20cancer&journal=Cancer&volume=71&pages=3926-3931&publication_year=1993&author=Veronese%2CSM&author=Gambacorta%2CM&author=Gottardi%2CO&author=Scanzi%2CF&author=Ferrari%2CM&author=Lampertico%2CP earning monthly?
• See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1845945 makes per month
• What's the income of http://scholar.google.com/scholar_lookup?&title=Ki-67%20immunostaining%20in%20human%20breast%20tumors%20and%20its%20relationship%20to%20prognosis&journal=Cancer&volume=67&pages=421-428&publication_year=1991&author=Wintzer%2CHO&author=Zipfel%2CI&author=Schulte-M%C3%B6nting%2CJ&author=Hellerich%2CU&author=Kleist%2CS?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1648433 gross monthly?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Ki-67%20immunostaining%20in%20node-negative%20stage%20I%2FII%20breast%20carcinoma&journal=Cancer&volume=68&pages=549-557&publication_year=1991&author=Sahin%2CAA&author=Jungsil%2CR&author=Jae%2CYR&author=Blick%2CMB&author=El-Naggar%2CAK&author=Ordonez%2CNG&author=Fritsche%2CHA&author=Smith%2CTL&author=Hortobagyi%2CGN&author=Ayala%2CAG generate?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1756257?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Immunohistochemical%20evaluation%20of%20growth%20fractions%20in%20human%20breast%20cancers%20using%20monoclonal%20antibody%20Ki-67&journal=Breast%20Cancer%20Res%20Treat&volume=18&pages=149-154&publication_year=1991&author=Weikel%2CW&author=Beck%2CT&author=Mitze%2CM&author=Knapstein%2CPG?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2767105 net monthly?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Cell%20kinetics%20as%20a%20prognostic%20indicator%20in%20node-negative%20breast%20cancer&journal=Eur%20J%20Cancer%20Clin%20Oncol&volume=25&pages=1165-1171&publication_year=1989&author=Silvestrini%2CR&author=Daidone%2CMG&author=Valagussa%2CP&author=Fronzo%2CG&author=Mezzanotte%2CG&author=Bonadonna%2CG?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2380758?
• How much does http://scholar.google.com/scholar_lookup?&title=3H-thimidine-labeling%20index%20as%20a%20prognostic%20indicator%20in%20node-positive%20breast%20cancer&journal=J%20Clin%20Oncol&volume=8&pages=1321-1326&publication_year=1990&author=Silvestrini%2CR&author=Daidone%2CMG&author=Valagussa%2CP&author=Fronzo%2CG&author=Mezzanotte%2CG&author=Mariani%2CL&author=Bonadonna%2CG bring in each month?
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2790700
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=The%20relationship%20of%20flow%20cytometry%20to%20clinical%20and%20biologic%20characteristics%20in%20women%20with%20node-negative%20primary%20breast%20cancer&journal=Cancer&volume=64&pages=1894-1900&publication_year=1989&author=Muss%2CHB&author=Kute%2CTE&author=Case%2CD&author=Smith%2CLR&author=Booher%2CC&author=Long%2CR&author=Kammire%2CL&author=Gregory%2CB&author=Brockschmidt%2CJK?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2230896's revenue stream
• How much money does http://scholar.google.com/scholar_lookup?&title=Node-negative%20breast%20cancer%3A%20prognostic%20subgroups%20defined%20by%20tumor%20size%20and%20flow%20cytometry&journal=J%20Clin%20Oncol&volume=8&pages=2040-2046&publication_year=1990&author=O%27Reilly%2CSM&author=Camplejohn%2CDM&author=Barnes%2CDM&author=Millis%2CRR&author=Rubens%2CRD&author=Richards%2CMA make?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2918874?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Prediction%20of%20relapse%20or%20survival%20in%20patients%20with%20node%20negative%20breast%20cancer%20by%20DNA%20flow%20cytometry&journal=N%20Engl%20J%20Med&volume=320&pages=627-633&publication_year=1989&author=Clark%2CGM&author=Dressler%2CLG&author=Owens%2CMR&author=Pounds%2CG&author=Oldaker%2CT&author=McGuire%2CWL?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2778823?
• How much does http://scholar.google.com/scholar_lookup?&title=Correlation%20of%20pretreatment%20proliferative%20activity%20of%20breast%20cancer%20with%20the%20response%20to%20cytotoxic%20chemotherapy&journal=J%20Natl%20Cancer%20Inst&volume=81&pages=1383-1387&publication_year=1989&author=Remvikos%2CY&author=Beuzeboc%2CP&author=Zajdela%2CA&author=Voillemot%2CN&author=Magdelenat%2CH&author=Pouillart%2CP net monthly?
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1591092
• How much does http://scholar.google.com/scholar_lookup?&title=DNA%20flow%20cytometry%20and%20response%20to%20preoperative%20chemotherapy%20for%20primary%20breast%20cancer&journal=Eur%20J%20Cancer&volume=28&pages=681-683&publication_year=1992&author=O%27Reilly%2CSM&author=Camplejohn%2CRS&author=Rubens%2CRD&author=Richard%2CMA rake in every month?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7865857 bring in?
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Relationship%20of%20variations%20in%20cell%20kinetics%20induced%20by%20primary%20chemotherapy%20to%20tumor%20regression%20and%20prognosis%20in%20locally%20advanced%20breast%20cancer&journal=Breast%20Cancer%20Res%20Treat&volume=32&pages=311-318&publication_year=1994&author=Gardin%2CG&author=Alama%2CA&author=Rosso%2CR&author=Campora%2CE&author=Repetto%2CL&author=Pronzato%2CP&author=Merlini%2CL&author=Naso%2CC&author=Camoriano%2CA&author=Meazza%2CR&author=Barbieri%2CF&author=Baldini%2CE&author=Giannessi%2CPG&author=Conte%2CPF?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=283280
• See how much http://scholar.google.com/scholar_lookup?&title=Tritiated%20thymidine%20labeling%20index%20and%20response%20in%20human%20breast%20cancer&journal=J%20Natl%20Cancer%20Inst&volume=62&pages=513-515&publication_year=1979&author=Sulkes%2CA&author=Livingston%2CRB&author=Murphy%2CWK makes per month
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3679189 produce monthly?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Proliferative%20rates%20of%20non-Hodgkin%20lymphomas%20as%20assessed%20by%20Ki-67%20antibody&journal=Hum%20Pathol&volume=18&pages=1155-1159&publication_year=1987&author=Weiss%2CLM&author=Strickler%2CJG&author=Medeiros%2CLJ&author=Gerdes%2CJ&author=Stein%2CH&author=Warnke%2CRA?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7104953?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Flow%20cytometry%20in%20the%20diagnosis%20and%20classification%20of%20malignant%20lymphoma%20and%20leukemia&journal=Cancer&volume=50&pages=1122-1135&publication_year=1982&author=Diamond%2CLW&author=Bharat%2CNN&author=Rappaport%2CH is on a monthly basis
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=A%20comparative%20assessment%20of%20proliferating%20cell%20nuclear%20antigen%2C%20c-myc%20p62%2C%20and%20nucleolar%20organizer%20region%20staining%20in%20non-Hodgkin%20lymphomas%3A%20a%20histochemical%20and%20immunohistochemical%20study%20of%20200%20cases&journal=Human%20Pathol&volume=24&pages=371-377&publication_year=1993&author=Korkolopoulou%2CP&author=Patsouris%2CE&author=Pangalis%2CG&author=Tsenga%2CA&author=Elemenoglou%2CJ&author=Thomas-Tsangali%2CE&author=Spandidos%2CD&author=Kittas%2CC?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2605100 make?
• How much does http://scholar.google.com/scholar_lookup?&title=DNA%20content%20in%20high%20and%20intermediate%20grade%20non-Hodgkin%27s%20lymphoma%20%E2%80%94%20prognostic%20significance%20and%20clinico-pathological%20correlations&journal=Br%20J%20Cancer&volume=60&pages=904-910&publication_year=1989&author=Cowan%2CRA&author=Harris%2CM&author=Jones%2CM&author=Crowther%2CD generate monthly?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2379148 earning monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Low%20proliferative%20activity%20is%20associated%20with%20a%20favorable%20prognosis%20in%20peripheral%20T-cell%20lymphoma&journal=Cancer%20Res&volume=50&pages=4845-4848&publication_year=1990&author=Grierson%2CHL&author=Wooldridge%2CTN&author=Purtilo%2CDT&author=Pierson%2CJ&author=Bast%2CM&author=Wooldridge%2CL&author=Armitage%2CJO&author=Weisenburger%2CDD earn?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8486424
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Cell%20proliferation%20as%20a%20long-term%20prognostic%20factor%20in%20diffuse%20large-cell%20lymphomas&journal=Int%20J%20Cancer&volume=54&pages=231-236&publication_year=1993&author=Silvestrini%2CS&author=Costa%2CA&author=Boracchi%2CP&author=Giardini%2CR&author=Rilke%2CF?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8123837?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Prognostic%20significance%20of%20the%20Ki-67-associated%20proliferative%20antigen%20in%20aggressive%20non-Hodgkin%20lymphomas%3A%20a%20prospective%20Southwest%20Oncology%20Group%20trial&journal=Blood&volume=83&pages=1460-1466&publication_year=1994&author=Miller%2CTP&author=Grogan%2CTM&author=Dahlberg%2CS&author=Spier%2CMC&author=Braziel%2CRM&author=Banks%2CPM&author=Foucar%2CK&author=Kjeldsberg%2CCR&author=Levy%2CN&author=Nathwani%2CBN&author=Schnitzer%2CB&author=Tubbs%2CRR&author=Gaynor%2CER&author=Fisher%2CRI generate?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3509751 generate?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Ploidy%2C%20proliferative%20activity%2C%20cluster%20differentiation%2C%20antigen%20expression%20and%20clinical%20remission%20in%20high-grade%20non-Hodgkin%20lymphoma&journal=Histopathology&volume=11&pages=1043-1054&publication_year=1987&author=Williamson%2CJMS&author=Grigor%2CI&author=Smith%2CMEF&author=Holgate%2CCS&author=O%27Brien%2CCJ&author=Morgan%2CDR&author=Quirke%2CP&author=Alison%2CDL&author=Child%2CJA&author=Bird%2CCC produce monthly?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6729213 pull in?
• How much money does http://scholar.google.com/scholar_lookup?&title=Relationship%20between%20estrogen%20receptors%20and%20cellular%20proliferation&journal=Recent%20Results%20Cancer%20Res&volume=91&pages=163-168&publication_year=1984&author=Silvestrini%2CR&author=Daidone%2CMG&author=Bertuzzi%2CA&author=Fronzo%2CG generate?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2482095 generate?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Correlation%20of%20growth%20fraction%20by%20Ki-67%20immunohistochemistry%20with%20histologic%20factors%20and%20hormone%20receptors%20in%20operable%20breast%20carcinoma&journal=Breast%20Cancer%20Res%20Treat&volume=14&pages=329-336&publication_year=1989&author=Gasparini%2CG&author=Fior%2CS&author=Pozza%2CF&author=Bevilacqua%2CP?
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8471553 have monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Prognostic%20significance%20of%20proliferative%20activity%20and%20ploidy%20in%20node-negative%20breast%20cancers&journal=Ann%20Oncol&volume=4&pages=213-219&publication_year=1993&author=Silvestrini%2CR&author=Daidone%2CMG&author=Bino%2CG&author=Mastore%2CM&author=Luisi%2CA&author=Fronzo%2CG&author=Boracchi%2CP gross monthly?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1985739
• How much profit does http://scholar.google.com/scholar_lookup?&title=A%20comparative%20study%20of%20histopathology%2C%20hormone%20receptors%2C%20peanut%20lectin%20binding%2C%20Ki-67%20immunostaining%20and%20nucleolar%20organizer%20region-associated%20proteins%20in%20human%20breast%20cancer&journal=Cancer&volume=67&pages=463-471&publication_year=1991&author=Stefano%2CD&author=Mingazzini%2CP&author=Scucchi%2CL&author=Donnetti%2CM&author=Marinozzi%2CV generate?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1987749 earns monthly
• What's the income of http://scholar.google.com/scholar_lookup?&title=Detection%20of%20Ki-67%20proliferation%20rate%20in%20breast%20cancer.%20Correlation%20with%20clinical%20and%20pathologic%20features&journal=Am%20J%20Clin%20Pathol&volume=95&pages=30-34&publication_year=1991&author=Veronese%2CSM&author=Gambacorta%2CM?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3945050?
• How much income is http://scholar.google.com/scholar_lookup?&title=Reliability%20and%20stability%20of%20the%20thymidine%20labeling%20index%20of%20breast%20carcinoma&journal=Lab%20Invest&volume=54&pages=160-164&publication_year=1986&author=Meyer%2CJS&author=McDivitt%2CRW earning monthly?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7371021?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Relationships%20of%20S-phase%20fraction%20of%20breast%20carcinoma%20in%20relapse%20to%20duration%20of%20remission%2C%20estrogen%20receptor%20content%2C%20therapeutic%20responsiveness%2C%20and%20duration%20of%20survival&journal=Cancer%20Res&volume=40&pages=1890-1896&publication_year=1980&author=Meyer%2CJS&author=Lee%2CJY
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1419299 bring in each month?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Biological%20characterisation%20of%20primary%20and%20methacronous%20lesions%20in%20breast%20cancer&journal=Eur%20J%20Cancer&volume=28A&pages=2006-2010&publication_year=1992&author=Silvestrini%2CR&author=Valentinis%2CB&author=Daidone%2CMG&author=Fronzo%2CG&author=Coradini%2CD&author=Salvadori%2CB
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Cancer%20of%20the%20breast&pages=1264-1332&publication_year=1993&author=Harris%2CJR&author=Morrow%2CM&author=Bonadonna%2CG bring in?
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8186426
• How much does http://scholar.google.com/scholar_lookup?&title=Programmed%20cell%20death%20%28apoptosis%29%20and%20response%20to%20anti-cancer%20drugs&journal=Anti-Cancer%20Drugs&volume=5&pages=3-9&publication_year=1994&author=Smets%2CLA gross monthly?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8324744?
• How much does http://scholar.google.com/scholar_lookup?&title=bcl-2%20modulation%20of%20apoptosis%20induced%20by%20anticancer%20drugs%3A%20resistance%20to%20thymidylate%20stress%20is%20independent%20of%20classical%20resistance%20pathways&journal=Cancer%20Res&volume=53&pages=3321-3326&publication_year=1993&author=Fisher%2CTC&author=Milner%2CAE&author=Gregory%2CCD&author=Jackman%2CAL&author=Aherne%2CGW&author=Hartley%2CJA&author=Dive%2CC&author=Hickman%2CJ bring in each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Drug%20resistance&pages=54-66&publication_year=1992&author=Goldie%2CJH net monthly?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1558352 earning monthly?
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Tumor%20proliferative%20rate%20and%20response%20to%20chemotherapy&journal=Ann%20Int%20Med&volume=116&pages=771-773&publication_year=1992&author=Armitage%2CJO?
• What's the income of https://citation-needed.springer.com/v2/references/10.1007/BF01806148?format=refman&flavour=references?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Andrea%20Bonetti's total income per month
• What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Andrea%20Bonetti%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marta%20Zaninelli's earnings
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marta%20Zaninelli%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Stefania%20Rodella generate?
• What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Stefania%20Rodella%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Annamaria%20Molino
• What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Annamaria%20Molino%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Loris%20Sperotto
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Loris%20Sperotto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Quirino%20Piubello earns monthly
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Quirino%20Piubello%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Franco%20Bonetti
• How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Franco%20Bonetti%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rolando%20Nortilli rake in every month?
• What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rolando%20Nortilli%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Monica%20Turazza make?
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Monica%20Turazza%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Gian%20Luigi%20Cetto?
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Gian%20Luigi%20Cetto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Learn how profitable https://s100.copyright.com/AppDispatchServlet?title=Tumor%20proliferative%20activity%20and%20response%20to%20first-line%20chemotherapy%20in%20advanced%20breast%20carcinoma&author=Andrea%20Bonetti%20et%20al&contentID=10.1007%2FBF01806148©right=Kluwer%20Academic%20Publishers&publication=0167-6806&publicationDate=1996-10&publisherName=SpringerNature&orderBeanReset=true is on a monthly basis
• Get to know https://citation-needed.springer.com/v2/references/10.1007/BF01806148?format=refman&flavour=citation's earnings
• Monthly income for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
• What's the financial intake of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
• Earnings of https://www.springernature.com/gp/products
• What's the financial outcome of https://www.springernature.com/gp/librarians?
• What's the financial gain of https://www.springernature.com/gp/societies?
• https://www.springernature.com/gp/partners's revenue stream
• https://www.springer.com/'s total income per month
• Explore the financials of https://www.nature.com/
• What's the total monthly financial gain of https://www.biomedcentral.com/?
• How much profit does https://www.palgrave.com/ make?
• How much money does https://www.apress.com/ make?
• https://www.springernature.com/gp/legal/ccpa income
• How much does https://www.springernature.com/gp/info/accessibility rake in every month?
• https://support.springernature.com/en/support/home's total income per month
• How much income does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations have?
• What's the total monthly financial gain of https://www.springernature.com/?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref